• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组化检测偶然前列腺癌患者行膀胱前列腺切除术前列腺组织中生长抑素受体亚型的表达

Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer.

机构信息

Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.

出版信息

BJU Int. 2010 Oct;106(7):1072-80. doi: 10.1111/j.1464-410X.2010.09238.x. Epub 2010 Mar 1.

DOI:10.1111/j.1464-410X.2010.09238.x
PMID:20201837
Abstract

OBJECTIVE

To examine immunohistochemically the expression of the five somatostatin receptors (SSTRs) in cystoprostatectomies (CyPs) with incidental prostate cancer.

MATERIALS AND METHODS

The five SSTRs (SSTR1-5) were evaluated in 'normal-looking' epithelium (NEp), high-grade prostatic intraepithelial neoplasia (HGPIN) and pT2a Gleason score 6 adenocarcinoma in 20 CyP specimens with incidental prostate cancer and 20 radical prostatectomy (RP) specimens with clinically detected prostate cancer.

RESULTS

For cytoplasm expression, the mean percentage of positive secretory cells with strong cytoplasmic staining increased from NEp to HGPIN and prostate cancer, being slightly lower in the CyP than in the RP specimens. Both in the CyP and RP specimens SSTR4 was found in the highest percentage of cells. There was membrane staining in the secretory cells for SSTR3 and SSTR4. There was nuclear staining in the secretory cells for SSTR4 and SSTR5. For SSTR1 and SSTR3 the mean proportions of positive basal cells were higher than for the other three subtypes, and greater in NEp than in HGPIN. There were positive smooth muscle and endothelial cells for all five SSTR subtypes, the highest proportions being SSTR1 and the lowest SSTR5.

CONCLUSIONS

This immunohistochemical study expands our knowledge of the expression and localization of SSTRs in the various tissue components in the prostate with incidental cancer, compared with clinically detected cancer. Such information might be useful in developing further non-invasive strategies for the prevention and treatment of pre-neoplastic and neoplastic lesions of the prostate.

摘要

目的

研究偶然发现前列腺癌的膀胱前列腺切除术(CyP)中五种生长抑素受体(SSTRs)的免疫组织化学表达。

材料与方法

在 20 例偶然发现前列腺癌的 CyP 标本和 20 例有临床前列腺癌的根治性前列腺切除术(RP)标本中,评估了五种 SSTRs(SSTR1-5)在“正常外观”上皮(NEp)、高级别前列腺上皮内瘤变(HGPIN)和 pT2a 级 6 分腺癌中的表达。

结果

对于细胞质表达,具有强细胞质染色的阳性分泌细胞的平均阳性百分比从 NEp 增加到 HGPIN 和前列腺癌,在 CyP 标本中略低于 RP 标本。在 CyP 和 RP 标本中,SSTR4 是细胞中发现百分比最高的。SSTR3 和 SSTR4 的分泌细胞有膜染色。SSTR4 和 SSTR5 的分泌细胞有核染色。对于 SSTR1 和 SSTR3,阳性基底细胞的平均比例高于其他三种亚型,在 NEp 中高于 HGPIN。所有五种 SSTR 亚型的平滑肌和内皮细胞均为阳性,SSTR1 的比例最高,SSTR5 的比例最低。

结论

与临床检测到的癌症相比,这项免疫组织化学研究扩展了我们对偶然发现癌症的前列腺中各种组织成分中 SSTRs 表达和定位的认识。这些信息可能有助于开发进一步的非侵入性策略,用于预防和治疗前列腺的前肿瘤和肿瘤病变。

相似文献

1
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer.免疫组化检测偶然前列腺癌患者行膀胱前列腺切除术前列腺组织中生长抑素受体亚型的表达
BJU Int. 2010 Oct;106(7):1072-80. doi: 10.1111/j.1464-410X.2010.09238.x. Epub 2010 Mar 1.
2
Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.ELAV 样蛋白 HuR 的过表达与萎缩、高级别前列腺上皮内瘤变和膀胱前列腺切除术中偶发前列腺癌中 COX-2 表达增加有关。
Eur Urol. 2009 Jul;56(1):105-12. doi: 10.1016/j.eururo.2008.04.043. Epub 2008 Apr 30.
3
Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation.免疫组织化学表达和定位在前列腺癌神经内分泌分化中的生长抑素受体亚型。
Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):511-22. doi: 10.1177/039463201002300213.
4
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.膀胱前列腺切除术中偶然发现的pT2a Gleason评分6分前列腺癌中的HER2表达及基因扩增:与临床检测的雄激素依赖性和雄激素非依赖性癌症的比较
Hum Pathol. 2006 Sep;37(9):1137-44. doi: 10.1016/j.humpath.2006.04.004. Epub 2006 Jun 21.
5
Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis.前列腺肿瘤过表达 1 在伴有偶发和非显著前列腺癌的膀胱前列腺切除术的免疫组化表达。前列腺癌发生的场效应的进一步证据。
Hum Pathol. 2011 Dec;42(12):1931-6. doi: 10.1016/j.humpath.2011.02.014. Epub 2011 Jun 14.
6
Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer.前列腺干细胞抗原在伴发偶发性前列腺癌的膀胱前列腺切除术中的免疫组化表达
Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):755-62. doi: 10.1177/039463200902200321.
7
Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer.内皮素-1、内皮素-A受体和内皮素-B受体在高级别前列腺上皮内瘤变和前列腺癌中的免疫组化表达
Eur Urol. 2007 Dec;52(6):1682-9. doi: 10.1016/j.eururo.2007.02.024. Epub 2007 Mar 12.
8
alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer.伴发前列腺癌的膀胱前列腺切除术中的α-甲基酰基辅酶A消旋酶、Ki-67和拓扑异构酶IIα
Am J Clin Pathol. 2007 Oct;128(4):657-66. doi: 10.1309/P065G467FKKUJDE5.
9
Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer.雄激素剥夺治疗后前列腺癌中生长抑素受体亚型的免疫组化表达和定位。
Cell Oncol (Dordr). 2011 Jun;34(3):235-43. doi: 10.1007/s13402-011-0031-y. Epub 2011 Apr 30.
10
Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.雄激素受体在前列腺上皮内瘤变和癌中的表达。
J Urol. 1999 Apr;161(4):1229-32.

引用本文的文献

1
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.靶向 Delta 样配体 3 的神经内分泌前列腺癌分子成像
J Nucl Med. 2022 Sep;63(9):1401-1407. doi: 10.2967/jnumed.121.263221. Epub 2022 Jan 20.
2
Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies.使用组织微阵列和特性明确的单克隆抗体对大量前列腺癌样本中的生长抑素和CXCR4受体表达进行评估。
Transl Oncol. 2020 Sep;13(9):100801. doi: 10.1016/j.tranon.2020.100801. Epub 2020 May 24.
3
Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET/CT: preliminary report of in six patients.
PET/CT 检测到去势抵抗性前列腺癌中生长抑素受体过表达:六例患者的初步报告。
Ann Transl Med. 2015 Jun;3(10):145. doi: 10.3978/j.issn.2305-5839.2015.06.10.
4
Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse.前列腺癌中生长抑素受体2亚型的缺失与侵袭性癌症表型、高肿瘤细胞增殖相关,并可预测早期转移和生化复发。
PLoS One. 2014 Jul 10;9(7):e100469. doi: 10.1371/journal.pone.0100469. eCollection 2014.
5
Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer.雄激素剥夺治疗后前列腺癌中生长抑素受体亚型的免疫组化表达和定位。
Cell Oncol (Dordr). 2011 Jun;34(3):235-43. doi: 10.1007/s13402-011-0031-y. Epub 2011 Apr 30.
6
Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma.激素难治性(去势抵抗性)前列腺癌中的生长抑素受体亚型。
Asian J Androl. 2011 Mar;13(2):242-7. doi: 10.1038/aja.2010.100. Epub 2010 Dec 13.